X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.biospace.com/article/releases/minerva-neurosciences-and-royalty-pharma-announce-sale-of-seltorexant-royalty-for-up-to-155-million/
https://www.globenewswire.com/news-release/2020/07/01/2056174/0/en/Minerva-Neurosciences-Exercises-Right-to-Opt-Out-of-Agreement-With-Janssen-for-Seltorexant-MIN-202.html#:~:text=(NASDAQ%3A%20NERV)%2C%20a,seltorexant%20(MIN%2D202).
https://www.fiercebiotech.com/biotech/minerva-s-sleep-drug-bests-ambien-placebo-dose-finding-study
https://endpts.com/minerva-claims-positive-phii-data-on-depression-drug-while-skeptics-pushes-stock-down/
Market Place
Share 
